MX2011011748A - Sistema intrauterino para uso en tratamiento medico. - Google Patents

Sistema intrauterino para uso en tratamiento medico.

Info

Publication number
MX2011011748A
MX2011011748A MX2011011748A MX2011011748A MX2011011748A MX 2011011748 A MX2011011748 A MX 2011011748A MX 2011011748 A MX2011011748 A MX 2011011748A MX 2011011748 A MX2011011748 A MX 2011011748A MX 2011011748 A MX2011011748 A MX 2011011748A
Authority
MX
Mexico
Prior art keywords
frame
deposit
uterus
intrauterine system
medical treatment
Prior art date
Application number
MX2011011748A
Other languages
English (en)
Inventor
Graaff Wouter De
Harm Veenstra
Titia Martine Truce Mulders
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2011011748A publication Critical patent/MX2011011748A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/26—Means for inserting tampons, i.e. applicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00—Metal working
    • Y10T29/49—Method of mechanical manufacture
    • Y10T29/49826—Assembling or joining

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe un sistema intrauterino (1) para uso en el tratamiento de sangrado uterino disfuncional; menorragia, dismenorrea, endometriosis, fibromas uterinos, síntomas climatéricos, osteoporosis y atrofia urogenital; el sistema está formado por: un armazón (16) que define un espacio interior (20) para recepción de un depósito (22) de una dosis terapéuticamente eficaz de un compuesto biológicamente activo; el armazón tiene una estructura abierta que permite el acceso a una parte sustancial de una superficie exterior del depósito, y el depósito tiene una estructura de control de tasa (26) que controla una tasa de liberación del compuesto dentro del útero; uno o más elementos de retención (6) están provistos en el armazón para retener el armazón dentro del útero de un mamífero hembra.
MX2011011748A 2009-05-04 2010-05-03 Sistema intrauterino para uso en tratamiento medico. MX2011011748A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159353 2009-05-04
PCT/EP2010/055948 WO2010128004A1 (en) 2009-05-04 2010-05-03 Intrauterine system for use in medical treatment

Publications (1)

Publication Number Publication Date
MX2011011748A true MX2011011748A (es) 2011-12-08

Family

ID=40943385

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011748A MX2011011748A (es) 2009-05-04 2010-05-03 Sistema intrauterino para uso en tratamiento medico.

Country Status (16)

Country Link
US (2) US8568374B2 (es)
EP (1) EP2427154A1 (es)
JP (1) JP5555766B2 (es)
KR (1) KR20120020151A (es)
CN (1) CN102438562B (es)
AU (1) AU2010244494B2 (es)
BR (1) BRPI1016147A2 (es)
CA (1) CA2760171A1 (es)
CO (1) CO6450625A2 (es)
IL (1) IL215842A (es)
MX (1) MX2011011748A (es)
MY (1) MY179350A (es)
NZ (1) NZ596005A (es)
RU (1) RU2529477C2 (es)
WO (1) WO2010128004A1 (es)
ZA (1) ZA201107862B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5670326B2 (ja) * 2008-06-25 2015-02-18 メディメトリクス ペルソナリズド ドルグ デリヴェリー ベー ヴェ 複数の薬剤リザーバを有する電子ピル
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
CA2736020C (en) 2008-09-17 2016-12-06 Bayer Oy An inserter
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
EP2464414B1 (en) 2009-08-12 2013-06-12 Medimetrics Personalized Drug Delivery B.V. Drug delivery device with compressible drug reservoir
CN103079632A (zh) * 2009-09-29 2013-05-01 梅迪梅特里科斯个性化药物传输私人有限公司 用于施用物质的子宫内电子胶囊
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
BR112015002746A2 (pt) * 2012-08-09 2017-07-04 Mithra Pharmaceuticals S A dispositivo intrauterino
US9339364B2 (en) * 2012-10-10 2016-05-17 The Procter & Gamble Company Intravaginal device withdrawal assembly
WO2014090976A1 (en) * 2012-12-14 2014-06-19 Laboratoire Hra-Pharma Copper intrauterine device
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US20160235583A1 (en) * 2013-02-21 2016-08-18 The Procter & Gamble Company Intravaginal device withdrawal assembly
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2016120402A1 (en) * 2015-01-30 2016-08-04 Ligalli B.V. Vaginal drug delivery device
WO2016171543A1 (en) 2015-04-22 2016-10-27 Cadens Beheer B.V. Improved contraceptive methods and compositions and devices for use therein
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR101851737B1 (ko) * 2016-04-26 2018-04-24 주식회사 엔도비전 자궁경부 유착 방지 장치
FR3078486B1 (fr) * 2018-03-01 2021-01-22 Steve Eisenhut Dispositif hygienique
ES1217271Y (es) * 2018-07-24 2018-12-05 Font Caselles Ramon Aplicador de tampones
MX2022005321A (es) * 2019-11-12 2022-08-11 Poly Med Inc Dispositivos medicos anticonceptivos.
TW202131879A (zh) * 2020-01-24 2021-09-01 芬蘭商拜耳股份有限公司 具備鎖定部件之子宮內系統
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656483A (en) * 1970-01-15 1972-04-18 Biolog Concepts Inc Intrauterine medicator
US4188951A (en) * 1972-08-17 1980-02-19 Alza Corporation Intrauterine system embracing selected copolymeric membranes for administering beneficial agent
US4102998A (en) 1972-10-02 1978-07-25 Morton Gutnick Process for the prevention of venereal disease
NL173707C (nl) 1974-02-14 1984-03-01 Multilan Sa Samenstel van intra-uterine anticonceptiemiddel en bijbehorende inbrenghuls.
US4341728A (en) 1979-12-20 1982-07-27 The Population Council, Inc. Method for making an IUD with shrinking of a medicated attachment onto a support
FR2577797A1 (fr) * 1985-02-22 1986-08-29 Benardin Henri Dispositif de contraception feminine
DE4125575C2 (de) 1991-08-02 1997-10-02 Piening Wolf Dietrich Dr Med Intrauterinpessar
FI97944C (fi) * 1994-07-05 1997-03-25 Leiras Oy Vaikuttavaa ainetta luovuttava laite
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
BE1014635A3 (es) * 2002-02-12 2004-02-03 Wildemeersch Dirk
EP1400258A1 (en) 2002-09-18 2004-03-24 Schering Oy Pharmaceutical composition delivery device and its manufacturing process
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
FR2881046A1 (fr) 2005-01-25 2006-07-28 7 Med Ind Sa Procede de fabrication d'un reservoir contenant une substance active diffusant a travers le reservoir et installation pour sa mise en oeuvre
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
EP2057972A1 (en) 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit

Also Published As

Publication number Publication date
ZA201107862B (en) 2012-09-26
IL215842A (en) 2013-02-28
BRPI1016147A2 (pt) 2016-04-19
CN102438562A (zh) 2012-05-02
US20100280464A1 (en) 2010-11-04
WO2010128004A1 (en) 2010-11-11
RU2529477C2 (ru) 2014-09-27
CN102438562B (zh) 2014-11-26
AU2010244494B2 (en) 2014-03-06
MY179350A (en) 2020-11-04
CO6450625A2 (es) 2012-05-31
US20140296833A1 (en) 2014-10-02
US8568374B2 (en) 2013-10-29
EP2427154A1 (en) 2012-03-14
CA2760171A1 (en) 2010-11-11
JP5555766B2 (ja) 2014-07-23
NZ596005A (en) 2013-02-22
KR20120020151A (ko) 2012-03-07
JP2012525861A (ja) 2012-10-25
RU2011149223A (ru) 2013-06-10
IL215842A0 (en) 2012-01-31
AU2010244494A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
MY179350A (en) Intrauterine system for use in medical treatment
MY188590A (en) Intrauterine deposit
JO3732B1 (ar) مشتقات 17-هيدروكسي-17بنتافلوروإيثيل-إسترا-4،9(10)-دين-11-أريل، طريقة لإنتاجها واستخدامها في معالجة الأمراض
TN2012000468A1 (en) Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
JP2012505021A5 (es)
WO2011009530A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
WO2011009529A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
IL207182A (en) Use of 17 alpha-acetoxy-11 beta- (4– n, n– dimethylamino phenyl) –19 – norfergana – 4, 9 – dian – 3, 20 – deion (Olipristal acetate) for the preparation of a drug to lower or stop bleeding in patients suffering from uterine fibroids
NZ609719A (en) Pharmaceutical composition
MX336209B (es) Suministro de formulaciones secas de octreótido.
AU2010314984A8 (en) Germline stem cell banking system
IL255679A (en) A dose of 1 mg to 100 mg of selective progesterone receptor modulator (sprm) for the treatment of endometriosis or uterine fibroids
WO2011009534A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
MY172530A (en) Method for treating gynecological diseases
MX2008000070A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona.
MX363979B (es) Forma de dosificacion de un antagonista del receptor de progesterona.
MX2012015102A (es) Agentes terapeuticos 976.
DOP2010000017A (es) Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva
TH115297B (th) ระบบที่อยู่ภายในมดลูก (Intrauterine System) สำหรับการใช้ในการบำบัดทางการแพทย์
MX2009013305A (es) Composicion farmaceutica de un nuevo sistema para liberacion vaginal de esteroides.
MX2009009515A (es) Cianopirrol sulfonamidas utiles para la modulacion del receptor de progesterona.
TH115297A (th) ระบบที่อยู่ภายในมดลูก (Intrauterine System) สำหรับการใช้ในการบำบัดทางการแพทย์
RO128263A2 (ro) Ovule trofice cervicovaginale-cervicotrofin
BRMU9000502U8 (pt) Dispositivo de regulagem de ajuste do suporte de disjuntores em quadro de distribuição

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: MERCK SHARP & DOHME B.V.

GB Transfer or rights

Owner name: MERCK SHARP & DOHME B.V.

GB Transfer or rights

Owner name: MERCK SHARP & DOHME B.V.

FG Grant or registration